Potential New Therapeutic Approaches for Renal Cell Carcinoma.

Seminars in Nephrology
David C Yang, Ching-Hsien Chen

Abstract

Renal cell carcinoma (RCC) is increasing in incidence and one third of newly diagnosed cases already are metastatic. The metastatic spread of solid tumors renders RCC incurable by surgical resection and consequently more difficult to treat. New molecular-targeted therapies have played a pivotal role in RCC treatment. Unfortunately, tumors frequently develop resistance to these targeted therapies by activating bypass pathways in which alternative signaling or biochemical pathways are activated in response to targeted inhibition of a signaling pathway, allowing cancer cells to continue to survive. Although the advent of immunotherapy with checkpoint inhibitors has led to significant changes in the treatment landscape for advanced RCC, many issues remain to be resolved. For these reasons, there is an urgent need to develop novel therapies and new treatment paradigms for patients with RCC. Much research has been performed thus far in identifying novel targets and treatment strategies in RCC and many of these currently are under investigation and/or in clinical trials. In this article, we discuss therapeutic options in the management of RCC with a focus on the new therapeutic approaches currently investigated in research and for use...Continue Reading

References

Jan 1, 1997·American Journal of Respiratory and Critical Care Medicine·K B BaumgartnerJ A Waldron
Nov 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Creg J WorkmanDario A A Vignali
Feb 24, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert H Vonderheide
Jul 25, 2008·Nature Reviews. Cancer·Gabriele Bergers, Douglas Hanahan
Jun 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstLee S Rosen
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matvey TsivianThomas J Polascik
Jun 12, 2013·The International Journal of Biochemistry & Cell Biology·Chi Han Li, Yangchao Chen
Jun 25, 2013·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 11, 2013·Proceedings of the National Academy of Sciences of the United States of America·Swati KushalParamjit S Arora
Nov 1, 2013·Nature Reviews. Drug Discovery·Hui LingGeorge A Calin
Nov 1, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Johanna C BendellSunil Sharma
Nov 19, 2013·Investigational New Drugs·Jonathan E RosenbergDamian A Laber
Nov 28, 2013·Expert Opinion on Emerging Drugs·Charlotte DomblidesAlain Ravaud
Jan 1, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian ShuchW Marston Linehan
Mar 7, 2014·Seminars in Interventional Radiology·Laura-Maria KrabbeChristopher G Wood
Apr 3, 2014·Cancer Research·J Louise LinesRandolph Noelle
Apr 3, 2014·Cancer Research·Isabelle Le MercierLi Wang
Apr 5, 2014·World Journal of Urology·Laura-Maria KrabbeVitaly Margulis
Jun 12, 2014·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Lorraine J GudasDavid M Nanus
Dec 3, 2014·Drug Discovery Today·Keld Fosgerau, Torsten Hoffmann
Nov 19, 2015·Acta Pharmaceutica Sinica. B·Georgina N Masoud, Wei Li
Mar 24, 2016·Nature Reviews. Clinical Oncology·Hollie J JacksonRenier J Brentjens
Apr 2, 2016·Cancer Immunology, Immunotherapy : CII·Cariad ChesterHolbrook E Kohrt
Jan 1, 2015·Oncolytic Virotherapy·Caroline J BreitbachJames Burke
Aug 31, 2016·Oncotarget·Josephine F TrottRobert H Weiss
Jan 19, 2017·Molecular Medicine Reports·Lu JinYongqing Lai
Mar 10, 2017·Nature Reviews. Disease Primers·James J HsiehVincenzo Ficarra
Mar 11, 2017·International Reviews of Immunology·Bahman AkbariLeila Rahbarnia
Apr 22, 2017·Experimental Biology and Medicine·Xiang SunLijuan Wan
May 16, 2017·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Gregory W Hosier, Naji J Touma
Jun 24, 2017·Cancer Treatment Reviews·J Molina-CerrilloE Grande
Jul 6, 2017·Nature·Patrick A OttCatherine J Wu
Jul 7, 2017·Oncology Reviews·Sittu Govindasamy Dinakaran Gangadaran
Jul 28, 2017·Archivum Immunologiae Et Therapiae Experimentalis·Olga Sokolowska, Dominika Nowis
Sep 30, 2017·CA: a Cancer Journal for Clinicians·Pedro C Barata, Brian I Rini
Nov 23, 2017·International Journal of Molecular Sciences·Lisa-Maria SchanzaVerena Stiegelbauer
Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patricia M Santos, Lisa H Butterfield
Jan 23, 2018·The Journal of Clinical Investigation·Silvia La PortaHellmut G Augustin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Protein and Peptide Letters
Min LiuZhicheng Gong
Hinyokika kiyo. Acta urologica Japonica
Yoichi MizutaniTsuneharu Miki
© 2021 Meta ULC. All rights reserved